MOOG INC. 10-Q
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
|
|
|
þ |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For
the quarterly period ended March 29, 2008
OR
|
|
|
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission
File Number: 1-5129
MOOG INC.
(Exact name of registrant as specified in its charter)
|
|
|
New York State
(State or Other Jurisdiction of Incorporation or Organization)
|
|
16-0757636
(I.R.S. Employer Identification No.) |
|
|
|
East Aurora, New York
(Address of Principal Executive Offices)
|
|
14052-0018
(Zip Code) |
Telephone number including area code: (716) 652-2000
Former name, former address and former fiscal year, if changed since last report.
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes þ No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer,
a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in
Rule 12b-2 of the Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated filer þ
|
|
Accelerated filer o
|
|
Non-accelerated filer o
|
|
Smaller reporting company o |
|
|
(Do not check if a smaller reporting company) |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o No þ
The number of shares outstanding of each class of common stock as of May 1, 2008 was:
Class A common stock, $1.00 par value 38,555,172 shares
Class B common stock, $1.00 par value 4,064,657 shares
MOOG INC.
QUARTERLY REPORT ON FORM 10-Q
TABLE OF CONTENTS
2
PART I FINANCIAL INFORMATION
Item 1. Financial Statements.
MOOG INC.
Consolidated Condensed Balance Sheets
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
March 29, |
|
|
September 29, |
|
(dollars in thousands) |
|
2008 |
|
|
2007 |
|
|
ASSETS |
|
|
|
|
|
|
|
|
CURRENT ASSETS |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
92,706 |
|
|
$ |
83,856 |
|
Receivables |
|
|
485,236 |
|
|
|
431,978 |
|
Inventories |
|
|
409,053 |
|
|
|
359,250 |
|
Other current assets |
|
|
70,914 |
|
|
|
61,767 |
|
|
|
|
|
|
|
|
TOTAL CURRENT ASSETS |
|
|
1,057,909 |
|
|
|
936,851 |
|
PROPERTY, PLANT AND EQUIPMENT, net of accumulated
depreciation of $392,470 and $361,120, respectively |
|
|
417,225 |
|
|
|
386,813 |
|
GOODWILL |
|
|
554,761 |
|
|
|
538,433 |
|
INTANGIBLE ASSETS, net |
|
|
79,293 |
|
|
|
81,916 |
|
OTHER ASSETS |
|
|
38,309 |
|
|
|
62,166 |
|
|
|
|
|
|
|
|
TOTAL ASSETS |
|
$ |
2,147,497 |
|
|
$ |
2,006,179 |
|
|
LIABILITIES AND SHAREHOLDERS EQUITY |
|
|
|
|
|
|
|
|
CURRENT LIABILITIES |
|
|
|
|
|
|
|
|
Notes payable |
|
$ |
1,653 |
|
|
$ |
3,354 |
|
Current installments of long-term debt |
|
|
2,568 |
|
|
|
2,537 |
|
Accounts payable |
|
|
128,903 |
|
|
|
113,942 |
|
Customer advances |
|
|
31,295 |
|
|
|
34,224 |
|
Contract loss reserves |
|
|
15,064 |
|
|
|
12,362 |
|
Other accrued liabilities |
|
|
165,265 |
|
|
|
153,809 |
|
|
|
|
TOTAL CURRENT LIABILITIES |
|
|
344,748 |
|
|
|
320,228 |
|
LONG-TERM DEBT, excluding current installments |
|
|
|
|
|
|
|
|
Senior debt |
|
|
461,395 |
|
|
|
411,543 |
|
Senior subordinated notes |
|
|
200,081 |
|
|
|
200,089 |
|
LONG-TERM PENSION AND RETIREMENT OBLIGATIONS |
|
|
142,443 |
|
|
|
113,354 |
|
DEFERRED INCOME TAXES |
|
|
63,042 |
|
|
|
80,419 |
|
OTHER LONG-TERM LIABILITIES |
|
|
5,067 |
|
|
|
3,334 |
|
|
|
|
TOTAL LIABILITIES |
|
|
1,216,776 |
|
|
|
1,128,967 |
|
|
|
|
SHAREHOLDERS EQUITY |
|
|
|
|
|
|
|
|
Common stock |
|
|
48,605 |
|
|
|
48,605 |
|
Other shareholders equity |
|
|
882,116 |
|
|
|
828,607 |
|
|
|
|
TOTAL SHAREHOLDERS EQUITY |
|
|
930,721 |
|
|
|
877,212 |
|
|
|
|
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY |
|
$ |
2,147,497 |
|
|
$ |
2,006,179 |
|
|
See accompanying Notes to Consolidated Condensed Financial Statements.
3
MOOG INC.
Consolidated Condensed
Statements of Earnings
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
March 29, |
|
|
March 31, |
|
|
March 29, |
|
|
March 31, |
|
(dollars in thousands, except per share data) |
|
2008 |
|
|
2007 |
|
|
2008 |
|
|
2007 |
|
|
NET SALES |
|
$ |
468,838 |
|
|
$ |
384,914 |
|
|
$ |
915,245 |
|
|
$ |
740,895 |
|
COST OF SALES |
|
|
319,203 |
|
|
|
256,425 |
|
|
|
617,980 |
|
|
|
491,724 |
|
|
|
|
GROSS PROFIT |
|
|
149,635 |
|
|
|
128,489 |
|
|
|
297,265 |
|
|
|
249,171 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
|
26,076 |
|
|
|
25,655 |
|
|
|
50,168 |
|
|
|
47,893 |
|
Selling, general and administrative |
|
|
72,939 |
|
|
|
60,749 |
|
|
|
144,221 |
|
|
|
117,495 |
|
Interest |
|
|
9,223 |
|
|
|
6,382 |
|
|
|
18,935 |
|
|
|
12,067 |
|
Other |
|
|
(1,131 |
) |
|
|
(535 |
) |
|
|
(1,017 |
) |
|
|
76 |
|
|
|
|
EARNINGS BEFORE INCOME TAXES |
|
|
42,528 |
|
|
|
36,238 |
|
|
|
84,958 |
|
|
|
71,640 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INCOME TAXES |
|
|
13,900 |
|
|
|
11,751 |
|
|
|
28,655 |
|
|
|
23,089 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET EARNINGS |
|
$ |
28,628 |
|
|
$ |
24,487 |
|
|
$ |
56,303 |
|
|
$ |
48,551 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET EARNINGS PER SHARE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
.67 |
|
|
$ |
.58 |
|
|
$ |
1.32 |
|
|
|
1.15 |
|
Diluted |
|
|
.66 |
|
|
|
.57 |
|
|
|
1.30 |
|
|
|
1.13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AVERAGE COMMON SHARES OUTSTANDING |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
42,601,255 |
|
|
|
42,421,490 |
|
|
|
42,543,291 |
|
|
|
42,369,585 |
|
Diluted |
|
|
43,242,298 |
|
|
|
43,102,869 |
|
|
|
43,250,479 |
|
|
|
43,059,806 |
|
|
See accompanying Notes to Consolidated Condensed Financial Statements.
4
MOOG INC.
Consolidated Condensed Statements of Cash Flows
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended |
|
|
|
March 29, |
|
|
March 31, |
|
(dollars in thousands) |
|
2008 |
|
|
2007 |
|
|
CASH FLOWS FROM OPERATING ACTIVITIES |
|
|
|
|
|
|
|
|
Net earnings |
|
$ |
56,303 |
|
|
$ |
48,551 |
|
Adjustments to reconcile net earnings to net cash (used) provided
by operating activities: |
|
|
|
|
|
|
|
|
Depreciation |
|
|
22,976 |
|
|
|
19,374 |
|
Amortization |
|
|
7,746 |
|
|
|
4,930 |
|
Provisions for non-cash losses on contracts, inventories and receivables |
|
|
14,298 |
|
|
|
12,594 |
|
Equity-based compensation expense |
|
|
2,310 |
|
|
|
2,200 |
|
Other |
|
|
(262 |
) |
|
|
(1,198 |
) |
Changes in assets and liabilities (using) providing cash, excluding the
effects of acquisitions: |
|
|
|
|
|
|
|
|
Receivables |
|
|
(44,105 |
) |
|
|
(26,103 |
) |
Inventories |
|
|
(48,206 |
) |
|
|
(38,344 |
) |
Customer advances |
|
|
(3,712 |
) |
|
|
2,912 |
|
Other assets and liabilities |
|
|
10,268 |
|
|
|
754 |
|
|
|
|
NET CASH PROVIDED BY OPERATING ACTIVITIES |
|
|
17,616 |
|
|
|
25,670 |
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES |
|
|
|
|
|
|
|
|
Acquisitions of businesses, net of acquired cash |
|
|
(9,101 |
) |
|
|
(85,453 |
) |
Purchase of property, plant and equipment |
|
|
(46,222 |
) |
|
|
(52,853 |
) |
Other |
|
|
(1,243 |
) |
|
|
1,117 |
|
|
|
|
NET CASH USED BY INVESTING ACTIVITIES |
|
|
(56,566 |
) |
|
|
(137,189 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES |
|
|
|
|
|
|
|
|
Net repayments of notes payable |
|
|
(1,878 |
) |
|
|
(1,610 |
) |
Net proceeds from revolving lines of credit |
|
|
47,000 |
|
|
|
124,000 |
|
Proceeds from long-term debt |
|
|
|
|
|
|
498 |
|
Payments on long-term debt |
|
|
(948 |
) |
|
|
(27,100 |
) |
Excess tax benefits from share-based payment arrangements |
|
|
811 |
|
|
|
901 |
|
Other |
|
|
(3,339 |
) |
|
|
1,771 |
|
|
|
|
NET CASH PROVIDED BY FINANCING ACTIVITIES |
|
|
41,646 |
|
|
|
98,460 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash |
|
|
6,154 |
|
|
|
1,691 |
|
|
|
|
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS |
|
|
8,850 |
|
|
|
(11,368 |
) |
Cash and cash equivalents at beginning of period |
|
|
83,856 |
|
|
|
57,821 |
|
|
|
|
CASH AND CASH EQUIVALENTS AT END OF PERIOD |
|
$ |
92,706 |
|
|
$ |
46,453 |
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH PAID FOR: |
|
|
|
|
|
|
|
|
Interest |
|
$ |
20,774 |
|
|
$ |
11,556 |
|
Income taxes, net of refunds |
|
|
19,531 |
|
|
|
19,425 |
|
|
See accompanying Notes to Consolidated Condensed Financial Statements.
5
MOOG INC.
Notes to Consolidated Condensed Financial Statements
Six Months Ended March 29, 2008
(Unaudited)
(dollars in thousands, except per share data)
Note 1 Basis of Presentation
The accompanying unaudited consolidated condensed financial statements have been prepared by
management in accordance with U.S. generally accepted accounting principles for interim financial
information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion
of management, all adjustments consisting of normal recurring adjustments considered necessary for
the fair presentation of results for the interim period have been included. The results of
operations for the three and six months ended March 29, 2008 are not necessarily indicative of the
results expected for the full year. The accompanying unaudited consolidated condensed financial
statements should be read in conjunction with the financial statements and notes thereto included
in our Form 10-K for the fiscal year ended September 29, 2007. All references to years in these
financial statements are to fiscal years.
Note 2 Acquisitions
All of our acquisitions are accounted for under the purchase method and, accordingly, the operating
results for the acquired companies are included in the consolidated statements of earnings from the
respective dates of acquisition.
On November 20, 2007, we acquired PRIZM Advanced Communication Electronics Inc. The purchase price,
net of cash acquired, was $12,000, which was financed with credit facility borrowings and issuance
of $3,000 of unsecured notes to the sellers payable on March 31, 2009. PRIZM specializes in the
design of fiber optic and wireless video and data multiplexers used in commercial and military
subsea markets for oil and gas exploration, terrestrial robots and remote sensing applications.
This acquisition is included in our Components segment.
On September 12, 2007, we acquired QuickSet International, Inc. The purchase price, net of cash
acquired, was $41,109, which was financed with credit facility borrowings. QuickSet is a
manufacturer of precision positioning systems and pan and tilt mechanisms. QuickSets products are
used to position surveillance cameras, thermal imagers, sensors and communication antennae for
military, homeland defense and commercial surveillance for securing national borders, commercial
ports, strategic missile silos and military protection systems. This acquisition is principally
included as part of our Space and Defense Controls segment and will contribute to growth in our
defense controls market and accelerate our business development in homeland security. Annual
sales for the twelve months preceding the acquisition were approximately $22,000. During 2008, we
completed our purchase price allocation for the acquisition and, as a result, goodwill increased by
$2,295 and intangible assets decreased by $2,081.
On September 6, 2007, we acquired Techtron, a commercial slip ring manufacturer, for $5,600 in
cash. This acquisition is included as part of our Components segment.
On May 3, 2007, we acquired Thermal Control Products Inc. The purchase price, net of cash acquired,
was $6,887. We paid $4,037 in cash, which was financed with credit facility borrowings, and issued
unsecured notes to the sellers payable over three years with a discounted present value of $2,850.
Thermal Control Products specializes in the design, prototype and manufacture of electronic cooling
and air moving systems for the automotive, telecommunications, server and electronic storage
markets and is included as part of our Components segment.
On March 16, 2007, we acquired ZEVEX International, Inc. The purchase price, net of cash acquired,
was $82,473, which was financed with credit facility borrowings, and $1,796 in assumed debt. ZEVEX
manufactures and distributes a line of ambulatory pumps, stationary pumps and disposable sets that
are used in the delivery of enteral nutrition for hospital, long-term care facilities, neonatal and
patient home use. ZEVEX also designs, develops and manufactures surgical tools and sensors and
provides engineered solutions for the medical marketplace. This acquisition further expands our
participation in medical markets. Annual sales for the twelve months preceding the acquisition were
approximately $43,000.
In the first quarter of 2007, we acquired a ball screw manufacturer. The adjusted purchase price
was $2,567 paid in cash and $2,935 in assumed debt.
Our purchase price allocations are substantially complete with the exception of PRIZMs purchase
price allocation, which is based on preliminary estimates of fair values of assets acquired and
liabilities assumed.
Note 3 Equity-Based Compensation
We have stock option plans that authorize the issuance of options for shares of Class A common
stock to directors, officers and key employees. Stock option grants are designed to reward
long-term contributions to Moog and provide incentives for recipients to remain with Moog. The 2003
Stock Option Plan authorizes the issuance of options for 1,350,000 shares of Class A common stock.
The 1998 Stock Option Plan authorizes the issuance of options for 2,025,000 shares of Class A
common stock. Under the terms of the plans, options may be either incentive or non-qualified. The
exercise price, determined by a committee of the Board of Directors, may not be less than the fair market value of the Class A common stock on the grant
date. Options become exercisable over periods not exceeding ten years.
6
On January 9, 2008, shareholders approved the 2008 Stock Appreciation Rights Plan. The 2008 Stock
Appreciation Rights Plan authorizes the issuance of 2,000,000 stock appreciation rights (SARs),
which represent the right to receive shares of Class A common stock. Under the terms of the plan,
the SARs are non-qualified for U.S. Federal income taxes. The exercise price of the SARs,
determined by a committee of the Board of Directors, may not be less than the fair value of the
Class A common stock on the grant date. The number of shares received upon exercise of SARs is
equal in value to the difference between the fair market value of the Class A common stock on the
exercise date and the exercise price of the SAR. The term of a SAR may not exceed ten years from
the date of grant.
Equity-based compensation expense is based on share-based payment awards that are ultimately
expected to vest. Vesting requirements vary for directors, officers and key employees. In general,
options granted to outside directors vest one year from the date of grant, options granted to
officers vest on various schedules and options granted to key employees vest in equal annual
increments over a five-year period from the date of grant.
Note 4 Inventories
|
|
|
|
|
|
|
|
|
|
|
March 29, |
|
|
September 29, |
|
|
|
2008 |
|
|
2007 |
|
|
Raw materials and purchased parts |
|
$ |
148,608 |
|
|
$ |
121,622 |
|
Work in progress |
|
|
203,795 |
|
|
|
183,810 |
|
Finished goods |
|
|
56,650 |
|
|
|
53,818 |
|
|
Total |
|
$ |
409,053 |
|
|
$ |
359,250 |
|
|
Note 5 Goodwill and Intangible Assets
The changes in the carrying amount of goodwill for the six months ended March 29, 2008 are as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of |
|
|
Current |
|
|
Adjustment |
|
|
Foreign |
|
|
Balance as of |
|
|
|
September 29, |
|
|
Year |
|
|
To Prior Year |
|
|
Currency |
|
|
March 29, |
|
|
|
2007 |
|
|
Acquisitions |
|
|
Acquisitions |
|
|
Translation |
|
|
2008 |
|
|
Aircraft Controls |
|
$ |
103,898 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
116 |
|
|
$ |
104,014 |
|
Space and Defense Controls |
|
|
67,546 |
|
|
|
|
|
|
|
2,157 |
|
|
|
|
|
|
|
69,703 |
|
Industrial Systems |
|
|
101,465 |
|
|
|
|
|
|
|
138 |
|
|
|
6,064 |
|
|
|
107,667 |
|
Components |
|
|
153,442 |
|
|
|
8,132 |
|
|
|
197 |
|
|
|
(864 |
) |
|
|
160,907 |
|
Medical Devices |
|
|
112,082 |
|
|
|
|
|
|
|
388 |
|
|
|
|
|
|
|
112,470 |
|
|
Total |
|
$ |
538,433 |
|
|
$ |
8,132 |
|
|
$ |
2,880 |
|
|
$ |
5,316 |
|
|
$ |
554,761 |
|
|
All acquired intangible assets other than goodwill are being amortized. The weighted-average
amortization period is eight years for customer-related, technology-related and marketing-related
intangible assets and ten years for artistic-related intangible assets. In total, these intangible
assets have a weighted-average life of eight years. Customer-related intangible assets primarily
consist of customer relationships. Technology-related intangible assets primarily consist of
technology, patents, intellectual property and engineering drawings. Marketing-related intangible
assets primarily consist of trademarks, tradenames and non-compete agreements.
Amortization of acquired intangible assets was $3,480 and $7,189 for the three and six months ended
March 29, 2008 and was $2,184 and $4,302 for the three and six months ended March 31, 2007,
respectively. Based on acquired intangible assets recorded at March 29, 2008, amortization is
expected to be $13,777 in 2008, $12,395 in 2009, $12,255 in 2010, $12,017 in 2011 and $11,378 in
2012. The gross carrying amount and accumulated amortization for major categories of acquired
intangible assets are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 29, 2008 |
|
|
September 29, 2007 |
|
|
|
Gross |
|
|
|
|
|
|
Gross |
|
|
|
|
|
|
Carrying |
|
|
Accumulated |
|
|
Carrying |
|
|
Accumulated |
|
|
|
Amount |
|
|
Amortization |
|
|
Amount |
|
|
Amortization |
|
|
Customer-related |
|
$ |
67,433 |
|
|
$ |
(20,038 |
) |
|
$ |
64,556 |
|
|
$ |
(15,181 |
) |
Technology-related |
|
|
32,620 |
|
|
|
(8,667 |
) |
|
|
30,560 |
|
|
|
(6,482 |
) |
Marketing-related |
|
|
15,236 |
|
|
|
(7,801 |
) |
|
|
15,229 |
|
|
|
(7,031 |
) |
Artistic-related |
|
|
25 |
|
|
|
(16 |
) |
|
|
25 |
|
|
|
(15 |
) |
|
Acquired intangible assets |
|
$ |
115,314 |
|
|
$ |
(36,522 |
) |
|
$ |
110,370 |
|
|
$ |
(28,709 |
) |
|
7
Note 6 Product Warranties
In the ordinary course of business, we warrant our products against defects in design, materials
and workmanship typically over periods ranging from twelve to thirty-six months. We determine
warranty reserves needed by product line based on historical experience and current facts and
circumstances. Activity in the warranty accrual is summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
March 29, |
|
|
March 31, |
|
|
March 29, |
|
|
March 31, |
|
|
|
2008 |
|
|
2007 |
|
|
2008 |
|
|
2007 |
|
|
Warranty accrual at beginning of period |
|
$ |
7,899 |
|
|
$ |
6,046 |
|
|
$ |
7,123 |
|
|
$ |
5,968 |
|
Additions from acquisitions |
|
|
100 |
|
|
|
159 |
|
|
|
100 |
|
|
|
159 |
|
Warranties issued during current period |
|
|
1,987 |
|
|
|
2,017 |
|
|
|
3,799 |
|
|
|
3,595 |
|
Reductions for settling warranties |
|
|
(1,202 |
) |
|
|
(1,517 |
) |
|
|
(2,329 |
) |
|
|
(3,134 |
) |
Foreign currency translation |
|
|
329 |
|
|
|
15 |
|
|
|
420 |
|
|
|
132 |
|
|
Warranty accrual at end of period |
|
$ |
9,113 |
|
|
$ |
6,720 |
|
|
$ |
9,113 |
|
|
$ |
6,720 |
|
|
Note 7 Derivative Financial Instruments
We have foreign currency exposure on intercompany loans that are denominated in a foreign currency
and are adjusted to current values using period-end exchange rates. The resulting gains or losses
are recorded in the statements of earnings. To minimize the foreign currency exposure, we have
foreign currency forwards with notional amounts of $13,231. The foreign currency forwards are
recorded in the balance sheet at fair value and resulting gains or losses are recorded in the
statements of earnings, generally offsetting the gains or losses from the adjustments on the
intercompany loans. At March 29, 2008, the fair value of the foreign currency forwards was a $544
asset, which was included in other current assets. At September 29, 2007, the fair value of the
foreign currency forwards was a $1,047 liability, which was included in other accrued liabilities.
We use derivative financial instruments to manage the risk associated with changes in interest
rates associated with long-term debt that affect the amount of future interest payments under our
U.S. credit facility. During the first six months of 2008, we entered into interest rate swaps with
notional amounts totaling $75,000. Based on the applicable margin at March 29, 2008, the interest
rate swaps effectively convert this amount of variable-rate debt to fixed-rate debt at 5.6% through
their maturities in 2010, at which time the interest will revert back to variable rates based on
LIBOR plus the applicable margin. Activity in Accumulated Other Comprehensive Income (AOCI) related
to derivatives held by us during the first six months of 2008 is summarized below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pre-Tax |
|
|
Income |
|
|
After-Tax |
|
|
|
Amount |
|
|
Tax |
|
|
Amount |
|
|
Accumulated gain at September 29, 2007 |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Net decrease in fair value of derivatives |
|
|
(2,115 |
) |
|
|
814 |
|
|
|
(1,301 |
) |
Net reclassification from AOCI into earnings |
|
|
16 |
|
|
|
(6 |
) |
|
|
10 |
|
|
Accumulated loss at March 29, 2008 |
|
$ |
(2,099 |
) |
|
$ |
808 |
|
|
$ |
(1,291 |
) |
|
To the extent that the interest rate swaps are not perfectly effective in offsetting the change in
the value of the interest payments being hedged, the ineffective portion of these contracts is
recognized in earnings immediately. Ineffectiveness was not material
in the first six months of 2008 or 2007. At March 29, 2008, the
fair value of interest rate swaps was a $2,200 liability, which is included in other accrued
liabilities and other long-term liabilities.
8
Note 8 Employee Benefit Plans
Net periodic benefit costs for U.S. pension plans consist of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
March 29, |
|
|
March 31, |
|
|
March 29, |
|
|
March 31, |
|
|
|
2008 |
|
|
2007 |
|
|
2008 |
|
|
2007 |
|
|
Service cost |
|
$ |
4,114 |
|
|
$ |
3,764 |
|
|
$ |
8,229 |
|
|
$ |
7,514 |
|
Interest cost |
|
|
5,860 |
|
|
|
5,207 |
|
|
|
11,719 |
|
|
|
10,412 |
|
Expected return on plan assets |
|
|
(7,452 |
) |
|
|
(6,373 |
) |
|
|
(14,905 |
) |
|
|
(12,746 |
) |
Amortization of prior service cost |
|
|
265 |
|
|
|
279 |
|
|
|
530 |
|
|
|
558 |
|
Amortization of actuarial loss |
|
|
689 |
|
|
|
1,133 |
|
|
|
1,379 |
|
|
|
2,266 |
|
Curtailment loss |
|
|
70 |
|
|
|
|
|
|
|
70 |
|
|
|
|
|
|
Pension expense for defined benefit plans |
|
|
3,546 |
|
|
|
4,010 |
|
|
|
7,022 |
|
|
|
8,004 |
|
Pension expense for defined contribution plans |
|
|
369 |
|
|
|
339 |
|
|
|
728 |
|
|
|
629 |
|
|
Total pension expense for U.S. plans |
|
$ |
3,915 |
|
|
$ |
4,349 |
|
|
$ |
7,750 |
|
|
$ |
8,633 |
|
|
Net periodic benefit costs for non-U.S. pension plans consist of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
March 29, |
|
|
March 31, |
|
|
March 29, |
|
|
March 31, |
|
|
|
2008 |
|
|
2007 |
|
|
2008 |
|
|
2007 |
|
|
Service cost |
|
$ |
995 |
|
|
$ |
928 |
|
|
$ |
1,964 |
|
|
$ |
1,843 |
|
Interest cost |
|
|
1,456 |
|
|
|
1,227 |
|
|
|
2,890 |
|
|
|
2,433 |
|
Expected return on plan assets |
|
|
(915 |
) |
|
|
(718 |
) |
|
|
(1,830 |
) |
|
|
(1,424 |
) |
Amortization of prior service credit |
|
|
(10 |
) |
|
|
(9 |
) |
|
|
(19 |
) |
|
|
(18 |
) |
Amortization of actuarial loss |
|
|
82 |
|
|
|
207 |
|
|
|
166 |
|
|
|
411 |
|
|
Pension expense for defined benefit plans |
|
|
1,608 |
|
|
|
1,635 |
|
|
|
3,171 |
|
|
|
3,245 |
|
Pension expense for defined contribution plans |
|
|
470 |
|
|
|
425 |
|
|
|
911 |
|
|
|
781 |
|
|
Total pension expense for non-U.S. plans |
|
$ |
2,078 |
|
|
$ |
2,060 |
|
|
$ |
4,082 |
|
|
$ |
4,026 |
|
|
During the six months ended March 29, 2008, we made contributions to our defined benefit pension
plans of $164 to the U.S. plans and $2,850 to the non-U.S. plans. We presently dont anticipate
contributing any additional amounts to the U.S. plans but do anticipate contributing $2,700 to the
non-U.S. plans in 2008 for a total of approximately $5,700.
Effective April 1, 2008, our U.S. defined benefit pension plan was amended to freeze enrollment of
new entrants. All new employees hired on or after January 1, 2008 are not eligible to participate
in the pension plan and, instead, we will make contributions for those employees to an
employee-directed investment fund in the Moog Inc. Retirement Savings Plan (RSP), formerly known as
the Moog Inc. Savings and Stock Ownership Plan (SSOP). The Companys contributions are based on a
percentage of the employees eligible compensation and age. These contributions are in addition to
the employer match.
We gave all current employees participating in the pension plan as of January 1, 2008 the option to
either remain in the pension plan and continue to accrue benefits or to elect to stop accruing
future benefits in the pension plan as of April 1, 2008 and instead receive the new Company
contribution in the RSP. The employee elections became effective April 1, 2008.
As a
result of the employee elections, there was an 18% reduction in
expected future service to be considered in calculating future
benefits under the pension plan. We
recognized a $70 curtailment loss in the second quarter of 2008 and remeasured both our obligation
and plan assets. The curtailment and remeasurement reduced other
assets by $21,845, increased long-term pension and retirement
obligations by $23,657 and resulted in an other comprehensive loss of
$27,936, net of deferred taxes of $17,496, due to a decrease in the funded status of the U.S defined
benefit pension plan as of March 29, 2008.
9
Net periodic benefit costs for the post-retirement health care benefit plan consist of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
March 29, |
|
|
March 31, |
|
|
March 29, |
|
|
March 31, |
|
|
|
2008 |
|
|
2007 |
|
|
2008 |
|
|
2007 |
|
|
Service cost |
|
$ |
107 |
|
|
$ |
101 |
|
|
$ |
214 |
|
|
$ |
201 |
|
Interest cost |
|
|
312 |
|
|
|
301 |
|
|
|
624 |
|
|
|
602 |
|
Amortization of transition obligation |
|
|
99 |
|
|
|
99 |
|
|
|
197 |
|
|
|
197 |
|
Amortization of prior service cost |
|
|
71 |
|
|
|
71 |
|
|
|
143 |
|
|
|
143 |
|
Amortization of actuarial loss |
|
|
112 |
|
|
|
129 |
|
|
|
224 |
|
|
|
260 |
|
|
Net periodic post-retirement benefit cost |
|
$ |
701 |
|
|
$ |
701 |
|
|
$ |
1,402 |
|
|
$ |
1,403 |
|
|
10
Note 9 Shareholders Equity
The changes in shareholders equity for the six months ended March 29, 2008 are summarized as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Shares |
|
|
|
|
|
|
|
Class A |
|
|
Class B |
|
|
|
|
|
|
|
Common |
|
|
Common |
|
|
|
Amount |
|
|
Stock |
|
|
Stock |
|
|
COMMON STOCK |
|
|
|
|
|
|
|
|
|
|
|
|
Beginning of period |
|
$ |
48,605 |
|
|
|
40,739,556 |
|
|
|
7,865,157 |
|
Conversion of Class B to Class A |
|
|
|
|
|
|
3,800 |
|
|
|
(3,800 |
) |
|
|
|
End of period |
|
|
48,605 |
|
|
|
40,743,356 |
|
|
|
7,861,357 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ADDITIONAL PAID-IN CAPITAL |
|
|
|
|
|
|
|
|
|
|
|
|
Beginning of period |
|
|
301,778 |
|
|
|
|
|
|
|
|
|
Equity-based compensation expense |
|
|
2,310 |
|
|
|
|
|
|
|
|
|
Issuance of Treasury shares at more than cost |
|
|
2,864 |
|
|
|
|
|
|
|
|
|
Income tax effect of equity-based compensation |
|
|
868 |
|
|
|
|
|
|
|
|
|
Adjustment to market SECT |
|
|
(845 |
) |
|
|
|
|
|
|
|
|
|
|
|
End of period |
|
|
306,975 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RETAINED EARNINGS |
|
|
|
|
|
|
|
|
|
|
|
|
Beginning of period |
|
|
570,063 |
|
|
|
|
|
|
|
|
|
Net earnings |
|
|
56,303 |
|
|
|
|
|
|
|
|
|
Adjustment for adoption of FIN 48 |
|
|
(546 |
) |
|
|
|
|
|
|
|
|
|
|
|
End of period |
|
|
625,820 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TREASURY STOCK |
|
|
|
|
|
|
|
|
|
|
|
|
Beginning of period |
|
|
(39,873 |
) |
|
|
(2,411,825 |
) |
|
|
(3,305,971 |
) |
Issuance of treasury shares |
|
|
1,411 |
|
|
|
264,529 |
|
|
|
|
|
Purchase of treasury shares |
|
|
(2,333 |
) |
|
|
(52,138 |
) |
|
|
|
|
|
|
|
End of period |
|
|
(40,795 |
) |
|
|
(2,199,434 |
) |
|
|
(3,305,971 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
STOCK EMPLOYEE COMPENSATION TRUST (SECT) |
|
|
|
|
|
|
|
|
|
|
|
|
Beginning of period |
|
|
(15,928 |
) |
|
|
|
|
|
|
(361,836 |
) |
Issuance of shares |
|
|
513 |
|
|
|
|
|
|
|
11,626 |
|
Purchases of shares |
|
|
(5,793 |
) |
|
|
|
|
|
|
(129,842 |
) |
Adjustment to market SECT |
|
|
845 |
|
|
|
|
|
|
|
|
|
|
|
|
End of period |
|
|
(20,363 |
) |
|
|
|
|
|
|
(480,052 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ACCUMULATED OTHER COMPREHENSIVE INCOME |
|
|
|
|
|
|
|
|
|
|
|
|
Beginning of period |
|
|
12,567 |
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
|
|
25,591 |
|
|
|
|
|
|
|
|
|
Retirement liability adjustment |
|
|
1,548 |
|
|
|
|
|
|
|
|
|
Pension curtailment and remeasurement impact |
|
|
(27,936 |
) |
|
|
|
|
|
|
|
|
Increase in accumulated loss on derivatives |
|
|
(1,291 |
) |
|
|
|
|
|
|
|
|
|
|
|
End of period |
|
|
10,479 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHAREHOLDERS EQUITY |
|
$ |
930,721 |
|
|
|
38,543,922 |
|
|
|
4,075,334 |
|
|
11
Note 10 Stock Employee Compensation Trust
The Stock Employee Compensation Trust (SECT) assists in administering and provides funding for
equity-based compensation plans and benefit programs, including the Moog Inc. Retirement Savings
Plan (RSP). The shares in the SECT are not considered outstanding for purposes of calculating
earnings per share. However, in accordance with the trust agreement governing the SECT, the SECT
trustee votes all shares held by the SECT on all matters submitted to shareholders.
Note 11 Earnings per Share
Basic and diluted weighted-average shares outstanding are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
March 29, |
|
|
March 31, |
|
|
March 29, |
|
|
March 31, |
|
|
|
2008 |
|
|
2007 |
|
|
2008 |
|
|
2007 |
|
|
Weighted-average shares outstanding Basic |
|
|
42,601,255 |
|
|
|
42,421,490 |
|
|
|
42,543,291 |
|
|
|
42,369,585 |
|
Dilutive effect of stock options |
|
|
641,043 |
|
|
|
681,379 |
|
|
|
707,188 |
|
|
|
690,221 |
|
|
Weighted-average shares outstanding Diluted |
|
|
43,242,298 |
|
|
|
43,102,869 |
|
|
|
43,250,479 |
|
|
|
43,059,806 |
|
|
Note 12 Comprehensive Income
The components of comprehensive income (loss), net of tax, are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
March 29, |
|
|
March 31, |
|
|
March 29, |
|
|
March 31, |
|
|
|
2008 |
|
|
2007 |
|
|
2008 |
|
|
2007 |
|
|
Net earnings |
|
$ |
28,628 |
|
|
$ |
24,487 |
|
|
$ |
56,303 |
|
|
$ |
48,551 |
|
Other comprehensive income (loss): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment |
|
|
19,624 |
|
|
|
2,610 |
|
|
|
25,591 |
|
|
|
9,773 |
|
Retirement liability adjustment, net of tax of $998 |
|
|
1,548 |
|
|
|
|
|
|
|
1,548 |
|
|
|
|
|
Pension curtailment and remeasurement, net of
tax of $17,496 |
|
|
(27,936 |
) |
|
|
|
|
|
|
(27,936 |
) |
|
|
|
|
Increase in accumulated loss on derivatives |
|
|
(872 |
) |
|
|
|
|
|
|
(1,291 |
) |
|
|
(86 |
) |
|
Comprehensive income |
|
$ |
20,992 |
|
|
$ |
27,097 |
|
|
$ |
54,215 |
|
|
$ |
58,238 |
|
|
The components of accumulated other comprehensive income (loss), net of tax, are as follows:
|
|
|
|
|
|
|
|
|
|
|
March 29, |
|
|
September 29, |
|
|
|
2008 |
|
|
2007 |
|
|
Cumulative foreign currency translation adjustment |
|
$ |
73,240 |
|
|
$ |
47,649 |
|
Accumulated
retirement liability adjustments |
|
|
(61,470 |
) |
|
|
(35,082 |
) |
Accumulated loss on derivatives |
|
|
(1,291 |
) |
|
|
|
|
|
Accumulated other comprehensive income |
|
$ |
10,479 |
|
|
$ |
12,567 |
|
|
12
Note 13 Segment Information
Below are sales and operating profit by segment for the three and six months ended March 29, 2008
and March 31, 2007 and a reconciliation of segment operating profit to earnings before income
taxes. Operating profit is net sales less cost of sales and other operating expenses, excluding
equity-based compensation expense and other corporate expenses. Cost of sales and other operating
expenses are directly identifiable to the respective segment or allocated on the basis of sales,
manpower or profit.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
March 29, |
|
|
March 31, |
|
|
March 29, |
|
|
March 31, |
|
|
|
2008 |
|
|
2007 |
|
|
2008 |
|
|
2007 |
|
|
Net sales: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aircraft Controls |
|
$ |
161,616 |
|
|
$ |
145,706 |
|
|
$ |
321,197 |
|
|
$ |
276,493 |
|
Space and Defense Controls |
|
|
70,086 |
|
|
|
47,200 |
|
|
|
127,433 |
|
|
|
90,865 |
|
Industrial Systems |
|
|
130,176 |
|
|
|
110,832 |
|
|
|
252,909 |
|
|
|
213,063 |
|
Components |
|
|
84,241 |
|
|
|
69,431 |
|
|
|
163,828 |
|
|
|
137,750 |
|
Medical Devices |
|
|
22,719 |
|
|
|
11,745 |
|
|
|
49,878 |
|
|
|
22,724 |
|
|
Net sales |
|
$ |
468,838 |
|
|
$ |
384,914 |
|
|
$ |
915,245 |
|
|
$ |
740,895 |
|
|
Operating profit and margins: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aircraft Controls |
|
$ |
14,255 |
|
|
$ |
14,561 |
|
|
$ |
29,343 |
|
|
$ |
27,880 |
|
|
|
|
8.8 |
% |
|
|
10.0 |
% |
|
|
9.1 |
% |
|
|
10.1 |
% |
Space and Defense Controls |
|
|
9,143 |
|
|
|
7,124 |
|
|
|
15,843 |
|
|
|
12,500 |
|
|
|
|
13.0 |
% |
|
|
15.1 |
% |
|
|
12.4 |
% |
|
|
13.8 |
% |
Industrial Systems |
|
|
18,284 |
|
|
|
14,779 |
|
|
|
36,177 |
|
|
|
28,278 |
|
|
|
|
14.0 |
% |
|
|
13.3 |
% |
|
|
14.3 |
% |
|
|
13.3 |
% |
Components |
|
|
14,584 |
|
|
|
9,839 |
|
|
|
29,420 |
|
|
|
22,954 |
|
|
|
|
17.3 |
% |
|
|
14.2 |
% |
|
|
18.0 |
% |
|
|
16.7 |
% |
Medical Devices |
|
|
349 |
|
|
|
1,138 |
|
|
|
3,936 |
|
|
|
3,283 |
|
|
|
|
1.5 |
% |
|
|
9.7 |
% |
|
|
7.9 |
% |
|
|
14.4 |
% |
|
Total operating profit |
|
|
56,615 |
|
|
|
47,441 |
|
|
|
114,719 |
|
|
|
94,895 |
|
|
|
|
12.1 |
% |
|
|
12.3 |
% |
|
|
12.5 |
% |
|
|
12.8 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deductions from operating profit: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
9,223 |
|
|
|
6,382 |
|
|
|
18,935 |
|
|
|
12,067 |
|
Equity-based compensation expense |
|
|
682 |
|
|
|
598 |
|
|
|
2,310 |
|
|
|
2,200 |
|
Corporate expenses and other |
|
|
4,182 |
|
|
|
4,223 |
|
|
|
8,516 |
|
|
|
8,988 |
|
|
Earnings before income taxes |
|
$ |
42,528 |
|
|
$ |
36,238 |
|
|
$ |
84,958 |
|
|
$ |
71,640 |
|
|
13
Note 14 Recent Accounting Pronouncements
In June 2006, the FASB issued FASB Interpretation No. 48, Accounting for Uncertainty in Income
Taxes (FIN 48). FIN 48 clarifies the accounting and reporting for income taxes recognized in
accordance with SFAS No. 109, Accounting for Income Taxes. FIN 48 prescribes a comprehensive
model for the financial statement recognition, measurement, presentation and disclosure of
uncertain tax positions taken or expected to be taken on income tax returns. We adopted the
provisions of FIN 48 on September 30, 2007. Previously, we had accounted for tax contingencies in
accordance with SFAS No. 5, Accounting for Contingencies. As required by FIN 48, which clarifies
SFAS No. 109, we recognized the financial statement benefit of a tax position only after
determining that the relevant tax authority would more likely than not sustain the position
following an audit. For tax positions meeting the more-likely-than-not threshold, the amount
recognized in the financial statements is the largest benefit that has a greater than 50 percent
likelihood of being realized upon ultimate settlement with the relevant tax authority. At the
adoption date, we applied FIN 48 to all tax positions for which the statute of limitations remained
open. As a result of the implementation of FIN 48, we recognized an increase of $546 in the
liability for unrecognized tax benefits, which was accounted for as a reduction to the September
30, 2007 balance of retained earnings.
The amount of unrecognized tax benefits as of September 30, 2007 was $1,452. That amount includes
$1,160 of unrecognized tax benefits, which, if ultimately recognized, will reduce our annual
effective tax rate. At March 29, 2008, the balance of unrecognized tax benefits increased to
$4,815. The increase from the beginning of the year is primarily the result of a $2,550 second
quarter increase related to the Companys reclassification of liabilities recorded in prior
periods. The March 29, 2008 balance of unrecognized tax benefits includes $4,556 of unrecognized
tax benefits, which, if ultimately recognized, will reduce the Companys annual effective tax rate.
We are subject to income taxes in the U.S. and in various states and foreign jurisdictions. Tax
regulations within each jurisdiction are subject to the interpretation of the related tax laws and
regulations and require significant judgment to apply. With few exceptions, we are no longer
subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities
for the years before 2005.
We are currently under examination by the Internal Revenue Service for 2005 and 2006. We expect
that examination will be concluded and settled in the next twelve months. We have unrecognized tax
benefits of $1,847 for those years. We believe it is reasonably possible that the resolution of
these examinations could result in payments ranging from $1,145 to $2,000.
We accrue interest and penalties related to unrecognized tax benefits in income tax expense for all
periods presented. We have accrued $152 for the payment of interest and penalties at September 30,
2007. Subsequent changes to accrued interest and penalties have not been significant.
In September 2006, the FASB issued SFAS No. 157, Fair Value Measurements. This statement
establishes a framework for measuring fair value in generally accepted accounting principles,
clarifies the definition of fair value within that framework, and expands disclosures about the use
of fair value measurement. SFAS No.157 is effective for fiscal years beginning after November 15,
2007 and interim periods within those fiscal years. We are currently evaluating the impact of
adopting SFAS No.157 on our consolidated financial statements.
In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and
Financial Liabilities. This statement permits entities to choose to measure many financial
instruments and certain other items at fair value. The objective is to improve financial reporting
by providing entities with the opportunity to mitigate volatility in reported earnings caused by
measuring related assets and liabilities differently without having to apply complex hedging
accounting provisions. SFAS No. 159 is effective for fiscal years beginning after November 15,
2007. We are currently evaluating the impact of adopting SFAS No. 159 on our consolidated financial
statements.
In December 2007, the FASB issued SFAS No. 141(R), Business Combinations. This statement replaces
SFAS No. 141. The objective of SFAS No. 141(R) is to improve the relevance, representational
faithfulness and comparability of the information that a reporting entity provides in its financial
reports about a business combination and its effects. It establishes principles and requirements
for the acquirer to recognize and measure the identifiable assets acquired, the liabilities
assumed, any noncontrolling interest in the acquiree, the goodwill acquired or a gain from a
bargain purchase. It also provides disclosure requirements to enable users of the financial
statements to evaluate the nature and financial effects of the business combination. SFAS No.
141(R) is effective for fiscal years beginning on or after December 15, 2008. Early adoption of
this statement is prohibited. We are currently evaluating the impact of adopting SFAS No. 141(R) on
our consolidated financial statements.
In December 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in Consolidated Financial
Statements-an amendment of ARB No. 51. The objective of SFAS No. 160 is to improve the relevance,
comparability and transparency of the financial information that a reporting entity provides in its
consolidated financial statements by establishing additional accounting and reporting standards.
SFAS No. 160 is effective for fiscal years beginning on or after December 15, 2008. Early adoption
of this statement is prohibited. We are currently evaluating the impact of adopting SFAS No. 160 on
our consolidated financial statements.
In March 2008, the FASB issued SFAS No. 161, Disclosures about Derivative Instruments and Hedging
Activities-an amendment of FASB Statement No. 133. The objective of SFAS No. 161 is to amend and
expand the disclosure requirements with the intent to provides users of financial statements with
an enhanced understanding of: (a) how and why an entity uses derivative instruments, (b) how
derivative instruments and related hedged items are accounted for under SFAS No. 133 and its
related interpretations and (c) how derivative instruments and related hedged items affect an
entitys financial position, financial
performance and cash flows. SFAS No. 161 is effective for fiscal years and interim periods
beginning after November 15, 2008. We are currently evaluating the impact of adopting SFAS No. 161
on our consolidated financial statements.
14
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations.
The following should be read in conjunction with Managements Discussion and Analysis of Financial
Condition and Results of Operations contained in the Companys Form 10-K for the fiscal year ended
September 29, 2007. All references to years in this Managements Discussion and Analysis of
Financial Condition and Results of Operations are to fiscal years.
OVERVIEW
We are a worldwide designer, manufacturer and integrator of precision control components and
systems. Our products and systems include military and commercial aircraft flight controls,
satellite positioning controls, controls for positioning gun barrels and automatic ammunition
loading for military combat vehicles, controls for steering tactical and strategic missiles, and
thrust vector controls for space launch vehicles. Our products are also used in a wide variety of
industrial applications, including injection molding machines for the plastics market, simulators
used to train pilots, power generating turbines, test equipment, metal forming, heavy industry and
certain medical applications. We operate under five segments, Aircraft Controls, Space and Defense
Controls, Industrial Systems, Components and Medical Devices. Our principal manufacturing
facilities are located in the United States, including facilities in New York, California, Utah,
Virginia, North Carolina, Pennsylvania, Ohio and Illinois, and in Germany, England, Italy, Japan,
the Philippines, Ireland and India.
Revenue under long-term contracts, representing approximately one-third of our sales, is recognized
using the percentage of completion, cost-to-cost method of accounting. This method of revenue
recognition is predominantly used within the Aircraft Controls and Space and Defense Controls
segments due to the long-term contractual nature of the business activities, with the exception of
their respective aftermarket activities. The remainder of our sales are recognized when the risks
and rewards of ownership and title to the product are transferred to the customer, principally as
units are delivered or as service obligations are satisfied. This method of revenue recognition is
predominantly used within the Industrial Systems, Components and Medical Devices segments, as well
as with aftermarket activity.
We intend to increase our revenue base and improve our profitability and cash flows from operations
by building on our market leadership positions and by strengthening our niche market positions in
the principal markets that we serve. We also expect to maintain a balanced, diversified portfolio
in terms of markets served, product applications, customer base and geographic presence. Our
strategy to achieve our objectives includes maintaining our technological excellence by building
upon our systems integration capabilities while solving our customers most demanding technical
problems, growing our profitable aftermarket business, entering and developing new markets by using
our broad expertise as a designer and supplier of precision controls, taking advantage of our
global engineering, selling and manufacturing capabilities, striving for continuing cost
improvements and capitalizing on strategic acquisition opportunities.
Challenges facing us include improving shareholder value through increased profitability while
experiencing pricing pressures from customers, strong competition and increases in costs such as
health care. We address these challenges by focusing on strategic revenue growth and by continuing
to improve operating efficiencies through various process and manufacturing initiatives and using
low cost manufacturing facilities without compromising quality.
Acquisitions
All of our acquisitions are accounted for under the purchase method and, accordingly, the operating
results for the acquired companies are included in the consolidated statements of earnings from the
respective dates of acquisition.
On November 20, 2007, we acquired PRIZM Advanced Communication Electronics Inc. The purchase price,
net of cash acquired, was $12 million, which was financed with credit facility borrowings and
issuance of $3 million of unsecured notes to the sellers payable on March 31, 2009. PRIZM
specializes in the design of fiber optic and wireless video and data multiplexers used in
commercial and military subsea markets, for oil and gas exploration, terrestrial robotics and
remote sensing applications. This acquisition is included in our Components segment.
On September 12, 2007, we acquired QuickSet International, Inc. The purchase price, net of cash
acquired, was $41 million, which was financed with credit facility borrowings. QuickSet is a
manufacturer of precision positioning systems and pan and tilt mechanisms. QuickSets products are
used to position surveillance cameras, thermal imagers, sensors and communication antennae for
military, homeland defense and commercial surveillance for securing national borders, commercial
ports, strategic missile silos and military protection systems. This acquisition is principally
included as part of our Space and Defense Controls segment and will accelerate business development
in our homeland security market. Annual sales for the twelve months preceding the acquisition were
approximately $22 million. During 2008, we completed our purchase price allocation for the
acquisition and, as a result, goodwill increased by $2 million and intangible assets decreased by
$2 million.
On September 6, 2007, we acquired Techtron, a commercial slip ring manufacturer, for $5.6 million
in cash. This acquisition is included as part of our Components segment.
On May 3, 2007, we acquired Thermal Control Products Inc. The purchase price, net of cash acquired,
was $7 million. We paid $4 million in cash, which was financed with credit facility borrowings, and
issued unsecured notes to the sellers payable over three years with a discounted present value of
$3 million. Thermal Control Products specializes in the design, prototype and manufacture of
electronic cooling and air moving systems for the automotive, telecommunications, server and
electronic storage markets and is included as part of our Components segment.
15
On March 16, 2007, we acquired ZEVEX International, Inc. The purchase price, net of cash acquired,
was $82 million, which was financed with credit facility borrowings, and $2 million in assumed
debt. ZEVEX manufactures and distributes a line of ambulatory pumps, stationary pumps and
disposable sets that are used in the delivery of enteral nutrition for hospital, long-term care
facilities, neonatal and patient home use. ZEVEX also designs, develops and manufactures surgical
tools and sensors and provides engineered solutions for the medical marketplace. This acquisition
further expands our participation in medical markets. Annual sales for the twelve months preceding
the acquisition were approximately $43 million.
In the first quarter of 2007, we acquired a ball screw manufacturer for $2.6 million in cash and
$2.9 million in assumed debt.
Our purchase price allocations are substantially complete with the exception of PRIZMs purchase
price allocation, which is based on preliminary estimates of fair values of assets acquired and
liabilities assumed.
CRITICAL ACCOUNTING POLICIES
There have been no changes in critical accounting policies in the current year from those disclosed
in our 2007 Form 10-K.
RECENT ACCOUNTING PRONOUNCEMENTS
In June 2006, the FASB issued FASB Interpretation No. 48, Accounting for Uncertainty in Income
Taxes (FIN 48). FIN 48 clarifies the accounting and reporting for income taxes recognized in
accordance with SFAS No. 109, Accounting for Income Taxes. FIN 48 prescribes a comprehensive
model for the financial statement recognition, measurement, presentation and disclosure of
uncertain tax positions taken or expected to be taken on income tax returns. We adopted the
provisions of FIN 48 on September 30, 2007. Previously, we had accounted for tax contingencies in
accordance with SFAS No. 5, Accounting for Contingencies. As required by FIN 48, which clarifies
SFAS No. 109, we recognized the financial statement benefit of a tax position only after
determining that the relevant tax authority would more likely than not sustain the position
following an audit. For tax positions meeting the more-likely-than-not threshold, the amount
recognized in the financial statements is the largest benefit that has a greater than 50 percent
likelihood of being realized upon ultimate settlement with the relevant tax authority. At the
adoption date, we applied FIN 48 to all tax positions for which the statute of limitations remained
open. As a result of the implementation of FIN 48, we recognized an increase of one-half million
dollars in the liability for unrecognized tax benefits, which was accounted for as a reduction to
the September 30, 2007 balance of retained earnings.
In September 2006, the FASB issued SFAS No. 157, Fair Value Measurements. This statement
establishes a framework for measuring fair value in generally accepted accounting principles,
clarifies the definition of fair value within that framework, and expands disclosures about the use
of fair value measurement. SFAS No.157 is effective for fiscal years beginning after November 15,
2007 and interim periods within those fiscal years. We are currently evaluating the impact of
adopting SFAS No. 157 on our consolidated financial statements.
In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and
Financial Liabilities. This statement permits entities to choose to measure many financial
instruments and certain other items at fair value. The objective is to improve financial reporting
by providing entities with the opportunity to mitigate volatility in reported earnings caused by
measuring related assets and liabilities differently without having to apply complex hedging
accounting provisions. SFAS No. 159 is effective for fiscal years beginning after November 15,
2007. We are currently evaluating the impact of adopting SFAS No. 159 on our consolidated financial
statements.
In December 2007, the FASB issued SFAS No. 141(R), Business Combinations. This statement replaces
SFAS No. 141. The objective of SFAS No. 141(R) is to improve the relevance, representational
faithfulness and comparability of the information that a reporting entity provides in its financial
reports about a business combination and its effects. It establishes principles and requirements
for the acquirer to recognize and measure the identifiable assets acquired, the liabilities
assumed, any noncontrolling interest in the acquiree, the goodwill acquired or a gain from a
bargain purchase. It also provides disclosure requirements to enable users of the financial
statements to evaluate the nature and financial effects of the business combination. SFAS No.
141(R) is effective for fiscal years beginning on or after December 15, 2008. Early adoption of
this statement is prohibited. We are currently evaluating the impact of adopting SFAS No. 141(R) on
our consolidated financial statements.
In December 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in Consolidated Financial
Statements-an amendment of ARB No. 51. The objective of SFAS No. 160 is to improve the relevance,
comparability and transparency of the financial information that a reporting entity provides in its
consolidated financial statements by establishing additional accounting and reporting standards.
SFAS No. 160 is effective for fiscal years beginning on or after December 15, 2008. Early adoption
of this statement is prohibited. We are currently evaluating the impact of adopting SFAS No. 160 on
our consolidated financial statements.
In March 2008, the FASB issued SFAS No. 161, Disclosures about Derivative Instruments and Hedging
Activities-an amendment of FASB Statement No. 133. The objective of SFAS No. 161 is to amend
and expand the disclosure requirements with the intent to provides users of financial statements
with an enhanced understanding of: (a) how and why an entity uses derivative instruments, (b) how
derivative instruments and related hedged items are accounted for under SFAS No. 133 and its
related interpretations and (c) how derivative instruments and related hedged items affect an
entitys financial position, financial performance and cash flows. SFAS No. 161 is effective for
fiscal years and interim periods beginning after November 15, 2008. We are currently evaluating the
impact of adopting SFAS No. 161 on our consolidated financial statements.
16
CONSOLIDATED RESULTS OF OPERATIONS AND OUTLOOK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
March 29, |
|
|
March 31, |
|
|
March 29, |
|
|
March 31, |
|
(dollars in millions) |
|
2008 |
|
|
2007 |
|
|
2008 |
|
|
2007 |
|
|
Net sales |
|
$ |
468.8 |
|
|
$ |
384.9 |
|
|
$ |
915.2 |
|
|
$ |
740.9 |
|
Gross margin |
|
|
31.9 |
% |
|
|
33.4 |
% |
|
|
32.5 |
% |
|
|
33.6 |
% |
Research and development expenses |
|
$ |
26.1 |
|
|
$ |
25.7 |
|
|
$ |
50.2 |
|
|
$ |
47.9 |
|
Selling, general and administrative expenses as
a percentage of sales |
|
|
15.6 |
% |
|
|
15.8 |
% |
|
|
15.8 |
% |
|
|
15.9 |
% |
Interest expense |
|
$ |
9.2 |
|
|
$ |
6.4 |
|
|
$ |
18.9 |
|
|
$ |
12.1 |
|
Effective tax rate |
|
|
32.7 |
% |
|
|
32.4 |
% |
|
|
33.7 |
% |
|
|
32.2 |
% |
Net earnings |
|
$ |
28.6 |
|
|
$ |
24.5 |
|
|
$ |
56.3 |
|
|
$ |
48.6 |
|
|
Net sales increased $84 million in the second quarter of 2008 over the second quarter of 2007 and
$174 million in the first half of the year over the comparable period a year ago. Sales increased
in each of our segments. Recent acquisitions contributed $42 million of the incremental sales in
the second quarter of 2008 and $75 million in the first half of 2008.
Our gross margin was lower in the second quarter of 2008 compared to 2007. Our gross margin was
affected by additions to contract loss reserves, which were $6 million higher in the second quarter
of 2008 compared to the second quarter of 2007, primarily related to a loss reserve in our Space
and Defense Controls segment. In addition, our Aircraft Controls margins were lower in the quarter
as a greater proportion of that business came from the cost-plus F-35 Joint Strike Fighter program.
Our gross margin was also lower in the first half of 2008 compared to 2007. Our Aircraft Controls
margins were lower in the first half of 2008 as a greater proportion of that business was on the
F-35 program. Also impacting our gross margin in the first half of 2008 were charges for purchase
accounting from recent acquisitions. These charge were $4 million higher in the first half of 2008
compared to 2007.
Research and development expenses were approximately the same in the second quarter of 2008
compared to the second quarter of 2007, however they increased $2 million in the first half of 2008
over the same period last year. The higher level of research and development expenses largely
resulted from the ZEVEX acquisition in our Medical Devices segment, while development activities on
a number of aircraft initiatives that increased were offset by a decline on the Boeing 787 program.
Selling, general and administrative expenses as a percentage of sales were down slightly compared
to the same periods last year in both the second quarter and first half of 2008 as we continue to
gain efficiencies associated with our higher sales volume.
Interest expense was higher in the second quarter and first half of 2008 compared to the same
periods in 2007. Higher debt levels associated with our acquisitions accounted for approximately
one-half of the increases while borrowings to fund working capital requirements and capital
expenditures contributed the other half. Partially offsetting the effect of higher debt levels in
the second quarter was a reduction in interest rates.
The effective tax rate for the second quarter of 2008 was comparable to the second quarter of 2007.
The effective tax rate for the first half of 2008 was higher than the first half of 2007 due to
additional tax exposures associated with foreign operations that were recorded in the first quarter
of 2008.
Net earnings increased 17% and 16% in the second quarter and first half of 2008, respectively, and
diluted earnings per share increased 16% and 15% in the second quarter and first half of 2008,
respectively.
2008 Outlook We expect sales in 2008 to increase 18% to approximately $1.85 billion with
increases in each of our segments. Sales are expected to increase $80 million in Industrial
Systems, $70 million in Aircraft Controls, $61 million in Space and Defense Controls, $47 million
in Components and $30 million in Medical Devices over 2007. We expect our operating margin to be
12.4% in 2008, comparable to the 12.5% level we achieved in 2007. Operating margins are expected to
increase in Industrial Systems and Components and decline in Medical Devices, Space and Defense
Controls and Aircraft Controls. We expect net earnings to increase to $117 million. We expect
diluted earnings per share to increase by approximately 16% to $2.71.
17
SEGMENT RESULTS OF OPERATIONS AND OUTLOOK
Operating profit, as presented below, is net sales less cost of sales and other operating expenses,
excluding equity-based compensation expense and other corporate expenses. Cost of sales and other
operating expenses are directly identifiable to the respective segment or allocated on the basis of
sales, manpower or profit. Operating profit is reconciled to earnings before income taxes in Note
13 of the Notes to Consolidated Condensed Financial Statements included in this report.
Aircraft Controls
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
March 29, |
|
|
March 31, |
|
|
March 29, |
|
|
March 31, |
|
(dollars in millions) |
|
2008 |
|
|
2007 |
|
|
2008 |
|
|
2007 |
|
|
Net sales military aircraft |
|
$ |
97.8 |
|
|
$ |
76.4 |
|
|
$ |
188.6 |
|
|
$ |
155.9 |
|
Net sales commercial aircraft |
|
|
63.8 |
|
|
|
69.3 |
|
|
|
132.6 |
|
|
|
120.6 |
|
|
|
|
$ |
161.6 |
|
|
$ |
145.7 |
|
|
$ |
321.2 |
|
|
$ |
276.5 |
|
Operating profit |
|
$ |
14.3 |
|
|
$ |
14.6 |
|
|
$ |
29.3 |
|
|
$ |
27.9 |
|
Operating margin |
|
|
8.8 |
% |
|
|
10.0 |
% |
|
|
9.1 |
% |
|
|
10.1 |
% |
Backlog |
|
|
|
|
|
|
|
|
|
$ |
309.3 |
|
|
$ |
297.5 |
|
|
Net sales in Aircraft Controls increased $16 million, or 11%, in the second quarter of 2008 and $45
million, or 16%, in the first half of 2008. Military aircraft sales increased $21 million in the
second quarter and $33 million in the first six months. Sales increased $13 million in the quarter
and $18 million in the first six months on the F-35 program as we design, develop and build
hardware for the conventional takeoff, short takeoff and carrier versions of the F-35. Military
aftermarket sales increased $3 million in the quarter and $6 million in the first six months. The
remaining increases in military aircraft sales relate to production programs including the Black
Hawk helicopter, the V-22 Osprey and the F/A-18 E/F Super Hornet. Commercial aircraft sales
decreased $6 million in the second quarter of 2008 compared to last year primarily related to lower
sales to Boeing. In the second quarter of 2007, we received our initial contract for the 787,
resulting in very strong sales. In addition, our sales to Boeing on their production aircraft
decreased in the second quarter of 2008 primarily related to the timing of receiving orders.
Commercial aircraft sales increased $12 million in the first six months, primarily related to a $9
million increase in business jets and $2 million related to the start up on the 787 contract in
last years second quarter.
Our operating margin was lower in the second quarter and first half of 2008 as a greater proportion
of sales came from the cost-plus F-35 program. This impact was partially offset by $4 million of
lower additions to contract loss reserves in the first half of 2008 compared to 2007.
Twelve-month backlog for Aircraft Controls increased to $309 million at March 29, 2008 from $298
million at March 31, 2007 due to strong commercial aircraft orders, particularly for business jets.
2008 Outlook for Aircraft Controls We expect sales in Aircraft Controls to increase 12% to $657
million in 2008. Military aircraft sales are expected to increase $55 million, or 17%, mainly due
to increases on the F-35 program, aftermarket and the V-22 program. Commercial aircraft sales are
expected to increase $15 million, or 6%, to $277 million, principally related to business jets. We
expect our operating margin to be 9.9% in 2008 compared to 10.4% in 2007. This decline is a result
of product mix shift to programs with lower margins.
18
Space and Defense Controls
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
March 29, |
|
|
March 31, |
|
|
March 29, |
|
|
March 31, |
|
(dollars in millions) |
|
2008 |
|
|
2007 |
|
|
2008 |
|
|
2007 |
|
|
Net sales |
|
$ |
70.1 |
|
|
$ |
47.2 |
|
|
$ |
127.5 |
|
|
$ |
90.9 |
|
Operating profit |
|
$ |
9.1 |
|
|
$ |
7.1 |
|
|
$ |
15.8 |
|
|
$ |
12.5 |
|
Operating margin |
|
|
13.0 |
% |
|
|
15.1 |
% |
|
|
12.4 |
% |
|
|
13.8 |
% |
Backlog |
|
|
|
|
|
|
|
|
|
$ |
168.8 |
|
|
$ |
124.8 |
|
|
Net sales in Space and Defense Controls increased $23 million, or 48%, in the second quarter of
2008 and $37 million, or 40%, in the first half of 2008. The increase resulted primarily from $23
million of sales from the recently acquired QuickSet business in the second quarter and $33 million
in the first half of 2008. QuickSet sales include $18 million and $24 million in the second quarter
and first half of 2008, respectively, on the Drivers Vision Enhancer (DVE) program in the defense
controls market. QuickSet also contributed $5 million in the quarter and $9 million in the first
half in sales of surveillance systems in our homeland security product line. The Constellation
program, which is replacing the Space Shuttle, generated $7 million and $10 million in the second
quarter and first half of 2008, respectively, which more than offset the $2 million and $5 million
declines in sales for the Space Shuttle in the second quarter and first half of 2008, respectively.
Our operating margin for Space and Defense Controls declined in the second quarter and first half
of 2008 as we established a $4 million loss reserve for thruster valves used on satellites. This
impact was offset by strong margins on the DVE program.
The higher level of twelve-month backlog at March 29, 2008 compared to March 31, 2007 relates to
orders for defense controls and homeland security products from the QuickSet acquisition and
increased orders on tactical missile programs.
2008 Outlook for Space and Defense Controls We expect sales in Space and Defense Controls to
increase 33% to $246 million in 2008. We expect increases in homeland security and defense controls
largely as a result of the QuickSet acquisition. We also expect an increase on the Constellation
program, which includes work on the Ares I Crew Launch and Orion Crew Exploration vehicles. We
expect our operating margin in 2008 to be 11.2%, down from 13.1% in 2007, mostly as a result of the
loss reserve on the satellite thruster valves.
Industrial Systems
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
March 29, |
|
|
March 31, |
|
|
March 29, |
|
|
March 31, |
|
(dollars in millions) |
|
2008 |
|
|
2007 |
|
|
2008 |
|
|
2007 |
|
|
Net sales |
|
$ |
130.2 |
|
|
$ |
110.8 |
|
|
$ |
252.9 |
|
|
$ |
213.1 |
|
Operating profit |
|
$ |
18.3 |
|
|
$ |
14.8 |
|
|
$ |
36.2 |
|
|
$ |
28.3 |
|
Operating margin |
|
|
14.0 |
% |
|
|
13.3 |
% |
|
|
14.3 |
% |
|
|
13.3 |
% |
Backlog |
|
|
|
|
|
|
|
|
|
$ |
192.4 |
|
|
$ |
120.3 |
|
|
Net sales in Industrial Systems increased $19 million, or 17%, in the second quarter of 2008 and
$40 million, or 19% in the first half of 2008. Stronger foreign currencies, in particular the euro,
compared to the U.S. dollar had a positive impact on sales, representing approximately half of the
sales increase in the second quarter and first half of the year. Sales were up in nearly all of our
major markets including simulation, metal forming and presses, power generation, heavy industry and
plastics making machinery. Sales growth in simulation of $4 million in the quarter and $9 million
for the first half of 2008 are a result of very strong deliveries to CAE and Flight Safety. Growth
in sales of controls for metal forming and presses of $4 million in the quarter and $7 million on a
year-to-date basis relates mostly to strong demand in Europe. Sales in power generation increased
$2 million in the quarter and first half and relates to strong demand in Asia. Sales growth in
heavy industry, which represents equipment used in steel mills, was $1 million in the second
quarter and $6 million in the first half, with increases coming mainly in China and Europe. Growth
in our sales of controls for plastics making machinery, our largest industrial market, increased
slightly in the quarter and increased $3 million in the first half of the year. In addition, we had
stronger sales in aftermarket, through our distribution network and in the oil and gas market.
Our operating margin for Industrial Systems improved in the second quarter and first half of 2008
over the comparable 2007 periods due to higher volume and operating efficiencies.
The higher level of twelve-month backlog for Industrial Systems at March 29, 2008 compared to March
31, 2007 primarily relates to orders in simulation, power generation and heavy industry markets.
2008 Outlook for Industrial Systems We expect sales in Industrial Systems to increase 18% to
$516 million in 2008. We expect sales growth in most of our major markets with the largest
increases in simulation and metal forming and presses. We expect our operating margin to be 14.3%
in 2008, an improvement over 13.2% in 2007, primarily due to the higher volume.
19
Components
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
March 29, |
|
|
March 31, |
|
|
March 29, |
|
|
March 31, |
|
(dollars in millions) |
|
2008 |
|
|
2007 |
|
|
2008 |
|
|
2007 |
|
|
Net sales |
|
$ |
84.2 |
|
|
$ |
69.4 |
|
|
$ |
163.8 |
|
|
$ |
137.8 |
|
Operating profit |
|
$ |
14.6 |
|
|
$ |
9.8 |
|
|
$ |
29.4 |
|
|
$ |
23.0 |
|
Operating margin |
|
|
17.3 |
% |
|
|
14.2 |
% |
|
|
18.0 |
% |
|
|
16.7 |
% |
Backlog |
|
|
|
|
|
|
|
|
|
$ |
177.0 |
|
|
$ |
129.9 |
|
|
Net sales in Components increased $15 million, or 21%, in the second quarter and $26 million, or
19%, in the first half of 2008. We experienced improvements in every market. The acquisitions of
Thermal Control Products, Techtron and PRIZM contributed $3 million of the sales increase in the
quarter and $7 million in the first six months. Marine sales increased $5 million in the quarter
and $8 million in the first half as the continuing increase in the price of oil drives demand.
Marine sales were also helped by the PRIZM acquisition. Sales of defense controls, including
components supplied on the Commanders Independent Viewer for the Bradley fighting vehicle,
increased $4 million in the second quarter and $6 million in the first half of 2008. Aircraft sales
increased $3 million in the second quarter and $5 million in the first half of 2008 due primarily
to the start-up of the Guardian program, a system designed to protect military and commercial
aircraft from shoulder-fired missiles. Industrial sales increased $3 million in the quarter and $6
million year-to-date, largely a result of the Thermal Control Products and Techtron acquisitions.
Our operating margin improved in both the second quarter and first half of 2008 relative to 2007
primarily as a result of sales volume.
The higher level of twelve-month backlog at March 29, 2008 compared to March 31, 2007 primarily
relates to increased orders for military aircraft programs and defense controls.
2008 Outlook for Components We expect sales in Components to increase 17% to $330 million in
2008, with increases in every market. We expect our operating margin to be 16.8% in 2008, an
improvement over the 15.7% level we achieved in 2007, primarily as a result of the sales volume
increases.
Medical Devices
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
March 29, |
|
|
March 31, |
|
|
March 29, |
|
|
March 31, |
|
(dollars in millions) |
|
2008 |
|
|
2007 |
|
|
2008 |
|
|
2007 |
|
|
Net sales |
|
$ |
22.7 |
|
|
$ |
11.7 |
|
|
$ |
49.9 |
|
|
$ |
22.7 |
|
Operating profit |
|
$ |
.3 |
|
|
$ |
1.1 |
|
|
$ |
3.9 |
|
|
$ |
3.3 |
|
Operating margin |
|
|
1.5 |
% |
|
|
9.7 |
% |
|
|
7.9 |
% |
|
|
14.4 |
% |
Backlog |
|
|
|
|
|
|
|
|
|
$ |
16.5 |
|
|
$ |
12.8 |
|
|
The Medical Devices segment was established in 2006 as a result of the acquisitions of Curlin
Medical and McKinley Medical. The acquisition of ZEVEX late in second quarter of 2007 further
expanded this segment. ZEVEX contributed $17 million and $35 million of sales for the second
quarter and first half of 2008, respectively, but only $2 million in the second quarter and first
half of 2007. Partially offsetting the effect of the ZEVEX acquisition were lower sales of
intravenous pumps, intravenous administration sets and disposable pumps.
The decrease in our operating margin is attributable to both the product mix and sales volume of
certain products. In both the second quarter and first half of 2008 compared to same periods of
2007, we had lower sales of higher margin intravenous pumps and administration sets. The ZEVEX
acquisition also impacted the product mix in both the second quarter and first half of 2008 with
sales of lower margin enteral pumps and the administration sets used with them. In addition,
research and development costs and selling, general and administrative expenses as a percentage of
sales increased.
Twelve-month backlog for Medical Devices is not as substantial as in our other segments, reflecting
the shorter order-to-shipment cycle for this line of business.
2008 Outlook for Medical Devices We expect sales in Medical Devices to be $98 million in 2008,
including a full year of ZEVEX sales. We expect our operating margin to decline in 2008 to 8.2%
from 10.2% in 2007, primarily as a result of product mix changes.
20
FINANCIAL CONDITION AND LIQUIDITY
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended |
|
|
|
March 29, |
|
|
March 31, |
|
(dollars in millions) |
|
2008 |
|
|
2007 |
|
|
Net cash provided (used) by: |
|
|
|
|
|
|
|
|
Operating activities |
|
$ |
17.6 |
|
|
$ |
25.7 |
|
Investing activities |
|
|
(56.6 |
) |
|
|
(137.2 |
) |
Financing activities |
|
|
41.6 |
|
|
|
98.5 |
|
|
Our available borrowing capacity and our cash flow from operations provide us with the financial
resources needed to run our operations, reinvest in our business and make strategic acquisitions.
Operating activities
Net cash provided by operating activities decreased in the first six months of 2008 compared to
2007. This decline relates principally to greater working capital requirements, especially
increased receivables and inventories to support the growth of our operations. Excluding
acquisitions, our sales increased 13% in the first six months of 2008 compared to 2007. The
increase in receivables is also influenced by our increased work on commercial aircraft programs
such as the Boeing 787 and business jets where payment terms typically do not benefit from progress
payments as work progresses, unlike some of our military programs.
Investing activities
Net cash used by investing activities in the first six months of 2008 consisted principally of $46
million for capital expenditures and $9 million towards the acquisition of PRIZM. The high level of
capital expenditures in the first six months of 2008 was driven by expansion of our facilities to
support our sales growth and spending for equipment for new production programs. Net cash used by
investing activities in the first six months of 2007 consisted of $82 million, net of cash
acquired, for the acquisition of ZEVEX and $53 million of capital expenditures for the 787
production program, facility expansions and other capital requirements. We also paid $3 million for
the acquisition of a ball screw manufacturer.
Based on the growth of our core businesses, we now project our capital expenditures to be
approximately $90 million in 2008.
Financing activities
Net cash provided by financing activities in the first six months of 2008 reflects the use of our
U.S. credit facility for increased working capital requirements to fund our sales growth, capital
expenditures and the acquisition of PRIZM. Net cash provided by financing activities in the first
six months of 2007 primarily reflects the use of our U.S. credit facility to fund the ZEVEX
acquisition in March 2007.
Off Balance Sheet Arrangements
We do not have any material off balance sheet arrangements that have or are reasonably likely to
have a material future effect on our results of operations or financial condition.
Contractual Obligations and Commercial Commitments
Our contractual obligations and commercial commitments have not changed materially from the
disclosures in our 2007 Form
10-K.
21
CAPITAL STRUCTURE AND RESOURCES
We maintain bank credit facilities to fund our short and long-term capital requirements, including
for acquisitions. From time to time, we also sell equity and debt securities to fund acquisitions
or take advantage of favorable market conditions.
On March 14, 2008, we amended our U.S. credit facility. Previously our credit facility consisted of
a $600 million revolver, which matured on October 25, 2011. Our new revolving credit facility,
which matures on March 14, 2013, increased our borrowing capacity to $750 million. The new
revolving credit facility had an outstanding balance of $449 million at March 29, 2008. Interest on
outstanding credit facility borrowings is based on LIBOR plus the applicable margin, which was 150
basis points at March 29, 2008. The credit facility is secured by substantially all of our U.S.
assets.
The U.S. credit facility contains various covenants. The covenant for minimum net worth, defined as
total shareholders equity adjusted to maintain the amounts of accumulated other comprehensive loss
at the level in existence as of September 30, 2006 is $600 million. The covenant for minimum
interest coverage ratio, defined as the ratio of EBITDA to interest expense for the most recent
four quarters, is 3.0. The covenant for the maximum leverage ratio, defined as the ratio of net
debt including letters of credit to EBITDA for the most recent four quarters, is 3.5. The covenant
for maximum capital expenditures is $100 million annually. EBITDA is defined in the loan agreement
as (i) the sum of net income, interest expense, income taxes, depreciation expense, amortization
expense, other non-cash items reducing consolidated net income and non-cash equity-based
compensation expenses minus (ii) other non-cash items increasing consolidated net income. We are in
compliance with all covenants.
We are required to obtain the consent of lenders of the U.S. credit facility before raising
significant additional debt financing. In recent years, we have demonstrated our ability to secure
consents to access debt markets. We have also been successful in accessing capital markets and have
shown strong, consistent financial performance. We believe that we will be able to obtain
additional debt or equity financing as needed.
At March 29, 2008, we had $338 million of unused borrowing capacity, including $289 million from
the U.S. credit facility after considering standby letters of credit.
Net debt to capitalization was 38% at both March 29, 2008 and September 29, 2007.
We believe that our cash on hand, cash flows from operations and available borrowings under short
and long-term lines of credit will continue to be sufficient to meet our operating needs.
22
ECONOMIC CONDITIONS AND MARKET TRENDS
Military Aerospace and Defense
Approximately 38% of our 2007 sales related to global military defense or government-funded
programs. Most of these sales were within Aircraft Controls and Space and Defense Controls.
The military aircraft market is dependent on military spending for development and production
programs. Military spending is expected to remain strong in the near term. Production programs are
typically long-term in nature, offering greater predictability as to capacity needs and future
revenues. We maintain positions on numerous high priority programs, including the F-35 Joint Strike
Fighter, F/A-18E/F Super Hornet and V-22 Osprey. These and other government programs can be
reduced, delayed or terminated. The large installed base of our products leads to attractive
aftermarket sales and service opportunities. Aftermarket revenues are expected to continue to
grow, due to military retrofit programs and increased flight hours resulting from increased
military activity.
The military and government space market is primarily dependent on the authorized levels of funding
for satellite communications needs and space exploration. We believe that long-term government
spending on military satellites will remain strong in order to satisfy the militarys need for
improved intelligence gathering. Funding for NASAs Constellation Program, the replacement for the
Space Shuttle, is expected to be solid in the coming years.
The tactical missile, missile defense and defense controls markets are dependent on many of the
same market conditions as military aircraft, including overall military spending and program
funding levels.
The market for homeland security and defense applications has gained momentum and acceptance over
the last few years and border security, transportation security and preparedness are high
priorities.
Industrial
Approximately 33% of our 2007 sales were generated in industrial markets. The industrial markets we
serve are influenced by several factors, including capital investment, product innovation, economic
growth, cost-reduction efforts and technology upgrades. Based on the high degree of sophistication
of our products and the niche markets we serve, we believe our business is not overly sensitive to
fluctuations in general macro-economic industrial trends. Our opportunities for growth include:
|
|
|
demand in China to support its economic growth particularly in power generation and
steel manufacturing markets, |
|
|
|
|
automotive manufacturers that are upgrading their metal forming, injection molding and
material test capabilities, |
|
|
|
|
increasing demand for aircraft training simulators and |
|
|
|
|
the need for precision controls on plastics injection molding machines to provide
improved manufacturing efficiencies. |
Commercial Aircraft
Approximately 18% of our 2007 sales were on commercial aircraft programs. The commercial OEM
aircraft market has historically exhibited cyclical swings and sensitivity to economic conditions.
The aftermarket, which is driven by usage of the existing aircraft fleet, has proven to be more
stable. Higher aircraft utilization rates result in the need for increased maintenance and spare
parts and enhance aftermarket sales. Boeing and Airbus are both increasing production levels for
new planes related to air traffic growth and further production increases are projected. We have
contract coverage through 2012 with Boeing for the existing 7-series aircraft and are also
developing flight control actuation systems for Boeings 787 Dreamliner. In the business jet
market, our flight controls on a couple of newer jets are in early production. Aftermarket revenues
are expected to grow as passenger miles continue to increase.
Medical
Approximately 8% of our 2007 sales were generated in medical markets. Demographics are aligned for
growth in the overall healthcare market. The medical markets that we operate in are influenced by
the need for precision control components and systems. Markets remain strong for brushless direct
current motors used in sleep apnea machines as well as fiber optic slip rings for CT scan
diagnostic imaging. Our enteral clinical nutrition products are gaining market share against more
typical Total Parenteral Nutrition. Our ultrasonic surgical tools are gaining new positions in
neurology and orthopedic markets due to higher performance and ease of use.
Foreign Currencies
We are affected by the movement of foreign currencies compared to the U.S. dollar, particularly in
Industrial Systems. About one-third of our 2007 sales were denominated in foreign currencies
including the euro, British pound and Japanese yen. During the first six months of 2008, these
foreign currencies strengthened against the U.S. dollar and the translation of the results of our
foreign subsidiaries into U.S. dollars contributed $26 million to the sales increase over the same
period one year ago. During 2007, these foreign currencies strengthened against the U.S. dollar and
the translation of the results of our foreign subsidiaries into U.S. dollars increased sales by $29
million compared to 2006.
23
Cautionary Statement
Information included herein or incorporated by reference that does not consist of historical facts,
including statements accompanied by or containing words such as may, will, should,
believes, expects, expected, intends, plans, projects, estimates, predicts,
potential, outlook, forecast, anticipates, presume and assume, are forward-looking
statements. Such forward-looking statements are made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. These statements are not guarantees of future
performance and are subject to several factors, risks and uncertainties, the impact or occurrence
of which could cause actual results to differ materially from the expected results described in the
forward-looking statements. These important factors, risks and uncertainties include (i)
fluctuations in general business cycles for commercial aircraft, military aircraft, space and
defense products, industrial capital goods and medical devices, (ii) our dependence on government
contracts that may not be fully funded or may be terminated, (iii) our dependence on certain major
customers, such as The Boeing Company and Lockheed Martin, for a significant percentage of our
sales, (iv) the possibility that the demand for our products may be reduced if we are unable to
adapt to technological change, (v) intense competition which may require us to lower prices or
offer more favorable terms of sale, (vi) our significant indebtedness which could limit our
operational and financial flexibility, (vii) the possibility that new product and research and
development efforts may not be successful which could reduce our sales and profits, (viii)
increased cash funding requirements for pension plans, which could occur in future years based on
assumptions used for our defined benefit pension plans, including returns on plan assets and
discount rates, (ix) a write-off of all or part of our goodwill, which could adversely affect our
operating results and net worth and cause us to violate covenants in our bank agreements, (x) the
potential for substantial fines and penalties or suspension or debarment from future contracts in
the event we do not comply with regulations relating to defense industry contracting, (xi) the
potential for cost overruns on development jobs and fixed price contracts and the risk that actual
results may differ from estimates used in contract accounting, (xii) the possibility that our
subcontractors may fail to perform their contractual obligations, which may adversely affect our
contract performance and our ability to obtain future business, (xiii) our ability to successfully
identify and consummate acquisitions, and integrate the acquired businesses and the risks
associated with acquisitions, including that the acquired businesses do not perform in accordance
with our expectations, and that we assume unknown liabilities in connection with the acquired
businesses for which we are not indemnified, (xiv) our dependence on our management team and key
personnel, (xv) the possibility of a catastrophic loss of one or more of our manufacturing
facilities, (xvi) the possibility that future terror attacks, war or other civil disturbances could
negatively impact our business, (xvii) that our operations in foreign countries could expose us to
political risks and adverse changes in local, legal, tax and regulatory schemes, (xviii) the
possibility that government regulation could limit our ability to sell our products outside the
United States, (xix) product quality or patient safety issues with respect to our medical devices
business that could lead to product recalls, withdrawal from certain markets, delays in the
introduction of new products, sanctions, litigation, declining sales or actions of regulatory
bodies and government authorities, (xx) the impact of product liability claims related to our
products used in applications where failure can result in significant property damage, injury or
death and in damage to our reputation, (xxi) the possibility that litigation may result unfavorably
to us, (xxii) our ability to adequately enforce our intellectual property rights and the
possibility that third parties will assert intellectual property rights that prevent or restrict
our ability to manufacture, sell, distribute or use our products or technology, (xxiii) foreign
currency fluctuations in those countries in which we do business and other risks associated with
international operations and (xxiv) the cost of compliance with environmental laws. The factors
identified above are not exhaustive. New factors, risks and uncertainties may emerge from time to
time that may affect the forward-looking statements made herein. Given these factors, risks and
uncertainties, investors should not place undue reliance on forward-looking statements as
predictive of future results. We disclaim any obligation to update the forward-looking statements
made in this report.
24
Item 3. Quantitative and Qualitative Disclosures about Market Risk.
Refer to the Companys Annual Report on Form 10-K for the year ended September 29, 2007 for a
complete discussion of our market risk. There have been no material changes in the current year
regarding this market risk information.
Item 4. Controls and Procedures.
(a) |
|
Disclosure Controls and Procedures.
Moog carried out an evaluation, under
the supervision and with the
participation of Company management,
including the Chief Executive Officer
and Chief Financial Officer, of the
effectiveness of the design and
operation of our disclosure controls
and procedures as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e).
Based on that evaluation, the Chief
Executive Officer and Chief Financial
Officer concluded that these disclosure
controls and procedures are effective
as of the end of the period covered by
this report, to ensure that information
required to be disclosed in reports
filed or submitted under the Exchange
Act is made known to them on a timely
basis, and that these disclosure
controls and procedures are effective
to ensure such information is recorded,
processed, summarized and reported
within the time periods specified in
the Commissions rules and forms. |
|
(b) |
|
Changes in Internal Control over
Financial Reporting. There have been
no changes in our internal control over
financial reporting during the most
recent fiscal quarter that have
materially affected, or are reasonably
likely to materially affect, our
internal control over financial
reporting. |
25
PART II OTHER INFORMATION
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
(c) The following table summarizes our purchases of our common stock for the quarter ended March 29, 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(d) Maximum Number |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(or Approximate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dollar Value) |
|
|
|
|
|
|
|
|
|
|
|
(c) Total Number of |
|
|
of Shares that |
|
|
|
|
|
|
|
|
|
|
|
Shares Purchased |
|
|
May Yet Be |
|
|
|
(a) Total Number of |
|
|
(b) Average Priced |
|
|
As Part of Publicly |
|
|
Purchased Under the |
|
|
|
Shares Purchased |
|
|
Paid |
|
|
Announced Plans or |
|
|
Plans or Programs |
|
Period |
|
(1)(2) |
|
|
Per Share |
|
|
Programs (2) |
|
|
(2) |
|
|
January 1 31, 2008 |
|
|
21,288 |
|
|
$ |
42.04 |
|
|
|
N/A |
|
|
|
N/A |
|
February 1 29, 2008 |
|
|
9,280 |
|
|
$ |
43.97 |
|
|
|
N/A |
|
|
|
N/A |
|
March 1 29, 2008 |
|
|
12,000 |
|
|
$ |
43.61 |
|
|
|
N/A |
|
|
|
N/A |
|
|
Total |
|
|
42,568 |
|
|
$ |
42.90 |
|
|
|
N/A |
|
|
|
N/A |
|
|
|
|
|
(1) |
|
Purchases in January include 16,705 shares from the Moog Inc. Retirement Savings Plan at $41.41 per share.
Purchases in March include 12,000 shares of Class B common stock from the Moog family at $43.61 per share.
|
|
(2) |
|
In connection with the exercise and vesting of stock options, we accept, from time to time, delivery of shares to
pay the exercise price of employee stock options. We do not otherwise have any plan or program to purchase our
common stock. During January, we accepted the delivery of 4,583 shares at $44.32 per share in connection with the
exercise of stock options. During February, we accepted the delivery of 9,280 shares at $43.97 per share in
connection with the exercise of stock options. |
Item 4. Submission of Matters to a Vote of Security Holders
The Companys Annual Meeting of Shareholders was held on January 9, 2008. The following matters were submitted to
a vote of security holders at the Annual Meeting.
(a) |
|
The Moog Inc. 2008 Stock Appreciation Rights Plan was approved based on the following votes:
Class A*: For, 3,126,589; Against, 134,277; Abstain, 2,878.
Class B: For, 4,034,700; Against, 72,159; Abstain, 6,496. |
|
(b) |
|
The nominees to the Board of Directors were elected based on the following votes: |
|
|
|
|
|
|
|
|
|
Nominee |
|
For |
|
Authority Withheld |
Class A |
|
|
|
|
|
|
|
|
Robert T. Brady |
|
|
31,934,567 |
|
|
|
3,988,693 |
|
Class B |
|
|
|
|
|
|
|
|
Joe C. Green |
|
|
4,318,700 |
|
|
|
67,497 |
|
Raymond W. Boushie |
|
|
4,350,662 |
|
|
|
35,535 |
|
|
|
The terms of the following directors continued after the Annual Meeting: Richard A. Aubrecht,
John D. Hendrick and Brian J. Lipke (Class B directors through 2009); and James L. Gray (Class
A director through 2009); Kraig H. Kayser, Robert H. Maskrey and Albert F. Myers (Class B
directors through 2010); and Robert R. Banta (Class A director through 2010). |
|
(c) |
|
The appointment of Ernst & Young LLP as auditors was approved based on the following votes:
Class A*: For, 3,583,151; Against, 7,379; Abstain 1,797.
Class B: For 4,359,285; Against, 25,119; Abstain, 1,794.
|
* |
|
Each share of Class A common stock is entitled to a one-tenth vote per share on this proposal. |
26
Item 6. Exhibits
(a) Exhibits
|
31.1 |
|
Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a) as adopted pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002. |
|
|
31.2 |
|
Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a) as adopted pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002. |
|
|
32.1 |
|
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
27
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
Moog Inc.
(Registrant)
|
|
Date: May 5, 2008 |
By |
/s/ Robert T. Brady
|
|
|
|
Robert T. Brady |
|
|
|
Chairman
Chief Executive Officer
(Principal Executive Officer) |
|
|
|
|
|
Date: May 5, 2008 |
By |
/s/ John R. Scannell
|
|
|
|
John R. Scannell |
|
|
|
Vice President
Chief Financial Officer
(Principal Financial Officer) |
|
|
|
|
|
Date: May 5, 2008 |
By |
/s/ Donald R. Fishback
|
|
|
|
Donald R. Fishback |
|
|
|
Vice President Finance |
|
|
|
|
|
Date: May 5, 2008 |
By |
/s/ Jennifer Walter
|
|
|
|
Jennifer Walter |
|
|
|
Controller
(Principal Accounting Officer) |
|
28
Exhibit Index
|
|
|
Exhibits |
|
|
Description |
|
|
|
|
|
31.1
|
|
Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a) as adopted pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002. |
|
|
|
31.2
|
|
Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a) as adopted pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002. |
|
|
|
32.1
|
|
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
29